Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl.

E Kragten; I Lalande; K Zimmermann; S Roggo; P Schindler; D Muller; J van Oostrum; P Waldmeier; P Furst

doi:10.1074/jbc.273.10.5821

Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl.

Identifier:nobleid.org/w1/20260515/EB081FDA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB081FDA.svg?ark=w1%2F20260515%2FEB081FDA)](https://nobleid.org/work/w1/20260515/EB081FDA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl.

Identifier:nobleid.org/w1/20260515/EB081FDA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB081FDA.svg?ark=w1%2F20260515%2FEB081FDA)](https://nobleid.org/work/w1/20260515/EB081FDA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work